Internalized stigma, anticipated discrimination and perceived public stigma in adults with ADHD.


Journal

Attention deficit and hyperactivity disorders
ISSN: 1866-6647
Titre abrégé: Atten Defic Hyperact Disord
Pays: Austria
ID NLM: 101491944

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 24 04 2018
accepted: 09 10 2018
pubmed: 21 10 2018
medline: 19 11 2019
entrez: 21 10 2018
Statut: ppublish

Résumé

The objective of this study is to assess internalized stigma, perceived public stigma, anticipated discrimination and their associations with demographic, psychiatric and psychosocial characteristics in adult ADHD. Stigmatization was assessed with the Internalized Stigma of Mental Illness Scale, the Questionnaire on Anticipated Discrimination and the Questionnaire on Public Stereotypes Perceived by Adults with ADHD. The sample comprised n = 104 adults with ADHD, of whom n = 24 (23.3%) reported high internalized stigma, n = 92 (88.5%) anticipated discrimination in daily life and n = 70 (69.3%) perceived public stigma. Internalized stigma and/or anticipated discrimination correlated with ADHD symptoms, psychological distress, self-esteem, functional impairment and quality of life and was associated with ADHD family history and employment status. Most frequently perceived stereotypes were doubts about the validity of ADHD as a mental disorder. Internalized stigma and anticipated discrimination are highly prevalent in adult ADHD and correlate with the burden of disease. ADHD is associated with characteristic public stereotypes, which are distinct from stereotypes related to other mental disorders. Stigmatization should be considered in the clinical management of adult ADHD and evaluated further in future studies.

Identifiants

pubmed: 30341693
doi: 10.1007/s12402-018-0274-9
pii: 10.1007/s12402-018-0274-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-220

Auteurs

Theresa Vera Masuch (TV)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, J 5, 68159, Mannheim, Germany.

Myriam Bea (M)

ADHS Deutschland e. V., Rapsstr. 61, 13629, Berlin, Germany.

Barbara Alm (B)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, J 5, 68159, Mannheim, Germany.

Peter Deibler (P)

Department of Psychosomatics, Protestant Hospital, Dr.-Kaufmann-Str. 2, 67098, Bad Duerkheim, Germany.

Esther Sobanski (E)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, J 5, 68159, Mannheim, Germany. esther.sobanski@zi-mannheim.de.
Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University Medical Center, Mainz, Germany. esther.sobanski@zi-mannheim.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH